Find a company
Search the SBRI Healthcare and NHS Cancer Programme Innovation Open call portfolio.
If you would like further information on any of the companies listed in the Directory please contact the SBRI Healthcare PMO by email sbri@lgcgroup.com or tel: +44 20 8843 8125.
We would be happy to make introductions to the companies or provide any further feedback you require.
At a glance
Directory search results
VODCA Limited
| Project | Augmented Microbiome-Mediated Breath Test for Earlier Oesophago-Gastric Cancer Diagnosis (AMBEC) |
|---|---|
| Description |
Oesophago-gastric cancer is among the world's top five cancers. Survival rates are very poor, the disease presents late and early symptoms are non-specific. We have developed a non-invasive test for oesophago-gastric adenocarcinoma (specificity 81%/sensitivity 85%) based on the detection of volatile organic compounds (VOCs) in exhaled breath. Our proposed innovation is to improve the accuracy of this test by means of an oral drink which induces the cancer-associated microbiome to produce still greater quantities of the distinctive VOCs and thereby allow patients with non-specific symptoms, yet at a high-risk of oesophago-gastric cancer, to be referred faster and earlier for endoscopy. |
| Funding | £ 83,333 |
| Competition | Competition 13 - Cancer: screening, earlier and faster diagnosis |
| Competition Date | September 2017 |
| Health Innovation Network Partner | Imperial College Health Partners AHSN |